Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lotem M et al. – Autologous melanoma cell vaccine is capable of inducing effective antimelanoma CD4 T–cell activity associated with improved survival. Patients with active metastatic disease generally displayed reduced immune response and gained little from active immunization.

Related Articles

Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09    Relevance Score: 70%

Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma
Clinics in Dermatology, 11/17/09    Relevance Score: 68%

Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey
Investigative Ophthalmology and Visual Science, 10/15/09    Relevance Score: 68%

Fine-needle aspiration cytology in a case of metastatic spindle cell melanoma in liver
Diagnostic Cytopathology, 11/11/09    Relevance Score: 67%

Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications
Scandinavian Journal of Rheumatology, 10/06/09    Relevance Score: 67%

Today in Dermatologic Oncology...keeping you current

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Clinical Cancer Research, 12/11/09

Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
The Journal of Pathology, 12/11/09

Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases
Clinical Cancer Research, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address